Lantheus Holdings Inc (LNTH)
US$ 76.83-1.81%
Price Chart
Key Statistics
Market Cap
$ 5.82B
P/E Ratio
23.88
Revenue (TTM)
$ 1.54B
Volume
1.2M
52W High
$ 126.89
52W Low
$ 73.11
Dividend Yield
0.00%
Beta
0.10
Technicals
50-Day MA
82.4796
200-Day MA
93.1049
52 Week High
126.8899
52 Week Low
73.11
About LNTH
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
Employees
808
Headquarters
Bedford, MA
CEO
Mr. Brian A. Markison
Latest News
(LNTH) Investment Report - news.stocktradersdaily.com
4 days ago • Google News
Lantheus Seems Worth The (Very Real) Risks (NASDAQ:LNTH) - Seeking Alpha
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg